CV Sciences Q3 revenue falls 7% amid regulatory pressure

By Reuters News


Overview

  • US hemp wellness firm's Q3 revenue fell 7% yr/yr amid regulatory headwinds

  • Company achieved positive adjusted EBITDA, reversing losses from prior year and previous quarter

  • Operating income turned positive, helped by lower expenses and a legal settlement gain


Outlook

  • Company continues to monitor potential restrictive federal regulations set for December 11, 2026

  • CV Sciences plans to focus on brand strength and expansion into broader wellness categories


Result Drivers

  • REGULATORY PRESSURE - Co said lower sales volumes and average prices were due to restrictive federal and state regulations

  • NEW PRODUCTS - 48% of Q3 net revenue came from products launched since January 2023, reflecting increased contribution from recent launches


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Sales

$3.03 mln

Q3 Net Loss

$93,000

Q3 Gross Profit

$1.51 mln

Q3 Operating Expenses

$1.14 mln

Q3 Operating Income

$377,000

Q3 Pretax Loss

$93,000


Reuters Recommended Reads

  • Nov 10 - Hims & Hers to offer peptides as soon as November after US eases curbs

  • Nov 12 - Health Canada warns after bacteria found in unauthorized peptides

  • Nov 10 - Corbus Pharmaceuticals Q3 net loss widens on higher expenses


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk